buy medicine online indiamedicine onlineloading...

    Formoterol + Budesonide

    Information about Formoterol + Budesonide

    Formoterol + budesonide uses

    Formoterol+Budesonide is used in the treatment of asthma and chronic obstructive pulmonary disease.

    How formoterol + budesonide works

    This is a combination of two medicines: Formoterol and Budesonide. Formoterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widens the airways. Budesonide is a steroid. It works by stopping the release of certain chemical messengers that cause inflammation (swelling) of the airways. Together, they make breathing easier.

    Common side effects of formoterol + budesonide

    Nausea, Vomiting, Respiratory tract infection, Hoarseness of voice, Fungal infections in the mouth, Cough, Headache, Sore throat, Musculoskeletal (bone, muscle or joint) pain, Increased heart rate
    Content Details
    author-image
    Written By
    Dr. Arpit Bhatnagar
    PGDHHM - Hospital and Healthcare Management, BDS
    author-image
    Reviewed By
    Dr. Lalit Kanodia
    MBA (Hospital Management), MD (Pharmacology)
    Last updated on:
    26 Dec 2018 | 05:35 PM (IST)
    editorial-image
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Formoterol + Budesonide

    • ₹134 to ₹890
      Cipla Ltd
      12 variant(s)
    • ₹19 to ₹388
      Lupin Ltd
      8 variant(s)
    • ₹172 to ₹543
      Zydus Cadila
      12 variant(s)
    • ₹118 to ₹389
      Macleods Pharmaceuticals Pvt Ltd
      7 variant(s)
    • ₹450 to ₹650
      AstraZeneca
      3 variant(s)
    • ₹137 to ₹441
      Glenmark Pharmaceuticals Ltd
      6 variant(s)
    • ₹202 to ₹372
      Dr Reddy's Laboratories Ltd
      5 variant(s)
    • ₹308 to ₹360
      Lupin Ltd
      2 variant(s)
    • ₹119 to ₹373
      Intas Pharmaceuticals Ltd
      8 variant(s)
    • ₹185 to ₹372
      Sun Pharmaceutical Industries Ltd
      6 variant(s)

    Expert advice for Formoterol + Budesonide

    • It contains two medicines in one inhaler for control of long term asthma and COPD symptoms.
    • It does not relieve sudden symptoms. Always use a rescue inhaler to treat sudden symptoms.
    • Tell your doctor immediately if your breathing problem worsens, or if rescue inhaler does not relieve symptoms.
    • Do not discontinue unless advised by your doctor.
    • Rinse your mouth with water after each use to prevent infections in the mouth and throat.
    • Carry your rescue inhaler wherever you go.

    Frequently asked questions for Formoterol + Budesonide

    Formoterol + Budesonide

    Q. What is Formoterol+Budesonide prescribed for?

    Formoterol+Budesonide is prescribed to treat Chronic Obstructive Pulmonary Disease and Asthma. The symptoms may include wheezing, shortness of breath, and breathing difficulties.

    Q. Can I stop taking Formoterol+Budesonide when my symptoms are relieved?

    No, do not stop taking Formoterol+Budesonide. If you stop taking Formoterol+Budesonide, your symptoms may come back and may lead to serious complications. Take your medicine as advised by your doctor.

    Q. Will Formoterol+Budesonide be more effective if taken in more than recommended dose?

    No, taking more of this medicine will not make it more effective, rather it can lead to increased side effects. If the symptoms are not getting relieved by the recommended doses, please consult the doctor for re-evaluation.

    Q. What are the instructions for storage and disposal of Formoterol+Budesonide?

    Keep this medicine in the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

    Q. When can I drink water after taking Formoterol+Budesonide?

    There are no restrictions on drinking water after taking Formoterol+Budesonide. However, it is better to rinse your mouth before drinking water to avoid ingestion of this medicine.

    Content on this page was last updated on 26 December, 2018, by Dr. Varun Gupta (MD Pharmacology)